IMCCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

IM Cannabis Corp.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 30, 2026

$1.50+0.11 (+7.91%)

Close on Oct 19, 2026

Fundamental chart

Pick a measure to chart its full history

C$54.73MFY2025, +34.9% a year since FY2019

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is IMCC.

Revenue growth1.3% · median 22.1%

Gross margin17.7% · median 35.5%

Operating margin-21.2% · median -28.1%

Net margin-20.7% · median -20.1%

Advertisement
300 × 250